172 related articles for article (PubMed ID: 9645459)
1. Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials.
Zeng ZC; Tang ZY; Liu KD; Lu JZ; Xie H; Yao Z
J Cancer Res Clin Oncol; 1998; 124(5):275-80. PubMed ID: 9645459
[TBL] [Abstract][Full Text] [Related]
2. Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion.
Zeng ZC; Tang ZY; Liu KD; Lu JZ; Cai XJ; Xie H
Cancer Immunol Immunother; 1994 Nov; 39(5):332-6. PubMed ID: 7987865
[TBL] [Abstract][Full Text] [Related]
3. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results.
Zeng ZC; Tang ZY; Xie H; Liu KD; Lu JZ; Chai XJ; Wang GF; Yao Z; Qian JM
J Cancer Res Clin Oncol; 1993; 119(5):257-9. PubMed ID: 8382704
[TBL] [Abstract][Full Text] [Related]
5. Observation of changes in peripheral T-lymphocyte subsets by flow cytometry in patients with liver cancer treated with radioimmunotherapy.
Zeng ZC; Tang ZY; Liu KD; Yu YQ; Yang BH; Cai XJ; Xie H; Cao SL
Nucl Med Commun; 1995 May; 16(5):378-85. PubMed ID: 7659390
[TBL] [Abstract][Full Text] [Related]
6. Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma.
Chen S; Li B; Xie H; Xu L; Niu G; Fan K; Fan Q
Cancer Biother Radiopharm; 2004 Oct; 19(5):589-600. PubMed ID: 15650451
[TBL] [Abstract][Full Text] [Related]
7. [Radioimmunoimaging (RII) and radioimmunotherapy (RIT) of human primary hepatic cancer (hPHC) with anti-PHC monoclonal antibody in tumor bearing nude mice].
Shi L; Wu M; Chen H
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):20-3. PubMed ID: 7656780
[TBL] [Abstract][Full Text] [Related]
8. Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.
Fan Z; Tang Z; Liu K; Zhou D; Lu J; Yuan A; Zhao H
J Cancer Res Clin Oncol; 1992; 118(5):371-6. PubMed ID: 1316355
[TBL] [Abstract][Full Text] [Related]
9. [Radioimmunologic targeting and therapy with antihuman primary hepatic cancer monoclonal antibodies (Hepama I) in patients].
Shi L; Wu M; Chen H
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):146-9. PubMed ID: 10743083
[TBL] [Abstract][Full Text] [Related]
10. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.
Chen ZN; Mi L; Xu J; Song F; Zhang Q; Zhang Z; Xing JL; Bian HJ; Jiang JL; Wang XH; Shang P; Qian AR; Zhang SH; Li L; Li Y; Feng Q; Yu XL; Feng Y; Yang XM; Tian R; Wu ZB; Leng N; Mo TS; Kuang AR; Tan TZ; Li YC; Liang DR; Lu WS; Miao J; Xu GH; Zhang ZH; Nan KJ; Han J; Liu QG; Zhang HX; Zhu P
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):435-44. PubMed ID: 16690431
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy for hepatocellular carcinoma (HCC) using 131I-anti HCC isoferritin IgG: preliminary results of experimental and clinical studies.
Liu KD; Tang ZY; Bao YM; Lu JZ; Qian F; Yuan AN; Zhao HY
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):319-23. PubMed ID: 2537805
[TBL] [Abstract][Full Text] [Related]
12. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection.
Tang ZY; Liu KD; Bao YM; Lu JZ; Yu YQ; Ma ZC; Zhou XD; Yang R; Gan YH; Lin ZY
Cancer; 1990 Jan; 65(2):211-5. PubMed ID: 1688507
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma (HCC)].
Li KD
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):430-2. PubMed ID: 1338985
[TBL] [Abstract][Full Text] [Related]
15. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer.
Ychou M; Azria D; Menkarios C; Faurous P; Quenet F; Saint-Aubert B; Rouanet P; Pèlegrin M; Bascoul-Mollevi C; Guerreau D; Saccavini JC; Mach JP; Artus JC; Pèlegrin A
Clin Cancer Res; 2008 Jun; 14(11):3487-93. PubMed ID: 18519781
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and localization of iodine-131-labeled metuximab in patients with hepatocellular carcinoma.
Zhang Z; Bian H; Feng Q; Mi L; Mo T; Kuang A; Tan T; Li Y; Lu W; Zhang Y; Zhang M; Tian R; Chen Z; Zhu P
Cancer Biol Ther; 2006 Mar; 5(3):318-22. PubMed ID: 16481737
[TBL] [Abstract][Full Text] [Related]
18. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
[TBL] [Abstract][Full Text] [Related]
19. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
20. Enhanced radioimmunotherapeutic efficacy of a monoclonal antibody cocktail against SMMC-7721 human hepatocellular carcinoma.
Song YQ; Wang GF; Dai XL; Xie H
Cell Res; 1998 Sep; 8(3):241-7. PubMed ID: 9791737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
